WHO ICTRP trial
A Multicenter Randomized Controlled Clinical Trial of Neoadjuvant Endocrine…
ChiCTR2500111780 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500111780 |
|---|---|
| Public title | A Multicenter Randomized Controlled Clinical Trial of Neoadjuvant Endocrine Therapy versus Chemotherapy in Patients with HR+/HER2- Early-Stage Breast Cancer |
| Scientific title | A Multicenter Randomized Controlled Clinical Trial of Neoadjuvant Endocrine Therapy versus Chemotherapy in Patients with HR+/HER2- Early-Stage Breast Cancer |
| Primary sponsor | Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | breast cancer |
| Interventions | Experimental Group:Ribociclib 400mg qd + Letrozole 2.5mg qd + Goserelin 3.6mg/28 days, with each cycle lasting 28 days, for a total of 5 cycles.;Contral Group:Chemotherapy: 4 cycles of epirubicin (100mg/m2, Q3W) + cyclophosphamide… |
| Registration date | Nov 5, 2025 |
| Target size | Experimental Group:74;Contral Group:74 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: